✦ LIBER ✦

Bladder cancer redefined

✍ Scribed by William M. Murphy

Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 40 KB
Volume: 86
Category: Article
ISSN: 0008-543X
DOI: 10.1002/(sici)1097-0142(19991115)86:10<1890::aid-cncr2>3.0.co;2-j

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bladder cancer

✍ Donald L. Lamm 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 1 views

Redefining a critical region of LOH on 4

Redefining a critical region of LOH on 4p16.3 in bladder cancer

✍ Kathryn Sibley; Sandra Bell; Margaret A. Knowles 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

Cancer and comorbidity : Redefining chro

Cancer and comorbidity : Redefining chronic diseases

✍ Karen S. Ogle; G. Marie Swanson; Nancy Woods; Faouzi Azzouz 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 2 views

A narrow subspecialty model of cancer care has led to cancer treatment often being given outside the full medical context of the patient. The full range of comorbid illness must be considered in all aspects of diagnosis and treatment. This study was conducted to describe the prevalence of comorbidit

Boundaries Redefined

✍ Chandra, Bhagya 📂 Fiction 📅 2015 🌐 English ⚖ 163 KB 👁 3 views

Love Redefined

✍ Foxx, Zoe 📂 Fiction 📅 2020 🏛 Independent 🌐 English ⚖ 90 KB 👁 2 views

Immunotherapy of bladder cancer

✍ Unyime O. Nseyo; Donald L. Lamm 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB 👁 2 views

Intravesical therapy has been used in the management of superficial transitional cell carcinoma (TCC) of the urinary bladder (i.e., Ta, Tl, and carcinoma in situ) with specific objectives which include treating existing/residual tumor, preventing recurrence of tumor, preventing disease progression,